BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2010
View Archived Issues
Clinical and preclinical data suggest potential of teneligliptin in diabetes
Read More
Elan Pharma reports effects of ELND-006 on Abeta in animals
Read More
Encouraging data disclosed on antidiabetes candidate TAK-875
Read More
Biolipox claims new LTC4 synthase inhibitors
Read More
Korean scientists disclose new inhibitors of Abeta neurotoxicity
Read More
Merck & Co. describes novel GPR109B receptor agonists
Read More
Novel HIF-1-alpha activators identified by sanofi-aventis
Read More
ABT-288 improves cognition in vivo
Read More
SAM-760 under clinical evaluation for treatment of AD
Read More
Clinical data on inhaled Technosphere insulin disclosed at ADA
Read More
FDA approves Lorus Therapeutics' IND for anticancer agent LOR-253
Read More
Watson Pharma licenses Itero's rFSH for female infertility
Read More
Health Canada clears phase III ReoT3D trial in head and neck cancer
Read More
Almirall presents novel S1P1 receptor agonists
Read More
Jevtana launched in U.S. for metastatic hormone-refractory prostate cancer
Read More
FDA approves Veltin gel for acne vulgaris in patients age 12 years and older
Read More
Takeda's Lampion pack approved in Japan
Read More
Geron begins phase II imetelstat trial in advanced non-small cell lung cancer
Read More
Phase II trial of interferon alfa-n3 for flu cleared in India
Read More
FDA begins NDA review for new oral rufinamide formulation
Read More
Tenofovir vaginal gel progresses in clinical trials for HIV prevention
Read More
Pfizer suspends tanezumab trials in chronic pain at request of FDA
Read More
Actelion's option to acquire Trophos depends on phase III olesoxime data
Read More
FLAP inhibitors enter phase II studies in asthma
Read More
Pharming finalizes divestment of DNage
Read More
